Zymergen Inc. (ZY): Price and Financial Metrics

Zymergen Inc. (ZY): $1.27

-0.05 (-3.79%)

POWR Rating

Component Grades













Add ZY to Watchlist
Sign Up

Industry: Chemicals



in industry

ZY Stock Price Chart Interactive Chart >

Price chart for ZY

ZY Price/Volume Stats

Current price $1.27 52-week high $46.05
Prev. close $1.32 52-week low $1.20
Day low $1.20 Volume 1,137,600
Day high $1.36 Avg. volume 1,061,415
50-day MA $2.27 Dividend yield N/A
200-day MA $7.16 Market Cap 130.99M

Zymergen Inc. (ZY) Company Bio

Zymergen Inc. designs, engineers, and optimizes microbes for industrial applications in United States, Asia, and Europe. The company has a platform that treats the genome as a search space, to identify genetic changes that improve the economics for its customers' bio-based products for a range of industries, including chemicals and materials, agriculture, and pharmaceuticals. Zymergen's platform is used to discover novel molecules used to enable unique material properties. The company was incorporated in 2013 and is based in Emeryville, California.

ZY Latest News Stream

Event/Time News Detail
Loading, please wait...

ZY Latest Social Stream

Loading social stream, please wait...

View Full ZY Social Stream

Latest ZY News From Around the Web

Below are the latest news stories about Zymergen Inc that investors may wish to consider to help them evaluate ZY as an investment opportunity.

What You Need To Know About Zymergen Inc.'s (NASDAQ:ZY) Investor Composition

A look at the shareholders of Zymergen Inc. ( NASDAQ:ZY ) can tell us which group is most powerful. Insiders often own...

Yahoo | February 22, 2022

Zymergen (ZY) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference

The following slide deck was published by Zymergen Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | January 24, 2022

Zymergen debuts Automation business and shares program portfolio

Zymergen (ZY) announces a new Automation business and updated portfolio

Seeking Alpha | January 11, 2022

Zymergen Debuts Automation Business and Shares Program Portfolio at 40th Annual JP Morgan Healthcare Conference

Delivering platform expertise and developing novel microbes, molecules and materials for customers across a variety of marketsSAN FRANCISCO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen (ZY) today announced a new Automation business and updated portfolio, further refining the company’s focus on high-value solutions where its proprietary platform can provide distinct advantages. Zymergen’s Automation business delivers proven automation technology to organizations interested in

Yahoo | January 11, 2022

Zymergen Announces Emerging Drug Discovery Business Enabled by One of the World’s Largest Metagenomics Databases and Proprietary Synthetic Biology Platform

Exploring natural products for innovative therapeuticsSAN FRANCISCO, Jan. 09, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen (ZY) announced a new drug discovery business based around their proprietary synthetic biology platform and what is believed to be the world’s largest metagenomics database, combining both size and quality. This new business leverages Zymergen’s differentiated access to natural products as a source of diverse chemical matter and augments Zymergen’s existing advance

Yahoo | January 10, 2022

Read More 'ZY' Stories Here

ZY Price Returns

1-mo -29.44%
3-mo -67.68%
6-mo -86.33%
1-year -96.38%
3-year N/A
5-year N/A
YTD -81.02%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.6993 seconds.